Two incretin-based drugs linked to increased bile duct disease but not pancreatitis
At least two incretin-based drugs – glucagon-like peptide 1 agonists and dipeptidyl peptidase 4 inhibitors – do not appear to increase the risk of acute pancreatitis in individuals with diabetes but...
Source: Hospitalist News - Category: Hospital Management Source Type: research
More News: Bile | Diabetes | Endocrinology | Hospital Management | Hospitalists | Incretin Therapy | Pancreatitis